SCHEMBL7521782

SCHEMBL7521782

Cc1ccccc1S(=O)(=O)OC(C)N(C)C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 1/20 0.39
POLB P06746 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NPSR1 Q6W5P4 3/20 0.37
LMNA P02545 3/20 0.37
JAK2 O60674 2/20 0.37
S1PR4 O95977 2/20 0.37
HPGD P15428 2/20 0.37
XBP1 P17861 2/20 0.37
HTT P42858 2/20 0.37
TP53 P04637 1/20 0.37
PKM P14618 1/20 0.37
ALOX15 P16050 1/20 0.37
S1PR1 P21453 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7521777 0.80 MMP13 (0.39) MMP13POLBMEN1KMT2ALMNA
SCHEMBL7521779 0.75 MMP13 (0.43) MMP13MEN1KMT2ANPSR1LMNA
SCHEMBL4936612 0.71 MEN1 (0.44) POLBMEN1KMT2ANPSR1LMNA
SCHEMBL14778954 0.71 MEN1 (0.44) POLBMEN1KMT2ANPSR1LMNA
SCHEMBL8960414 0.71 CYP1A2 (0.46) MMP13POLBMEN1KMT2AHTT
SCHEMBL8960400 0.71 CYP1A2 (0.46) MMP13POLBMEN1KMT2AHTT
SCHEMBL30599261 0.71 POLB (0.48) POLBMEN1KMT2ANPSR1HTT
SCHEMBL7901531 0.70 METAP2 (0.42) POLBMEN1KMT2ANPSR1LMNA
SCHEMBL7630224 0.69 KMT2A (0.43) POLBMEN1KMT2ANPSR1LMNA
SCHEMBL30034373 0.69 MTOR (0.53) MMP13GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1171127-A2 PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDINE OR PYRIMIDINE DERIVATIVES FOR INHIBITION OF CYTOKINE PRODUCTION AND SECRETION Targacept, Inc. (US) 2002-01-16 EP disclosed
WO-2000062767-A2 PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDINE OR PYRIMIDINE DERIVATES FOR INHIBITION OF CYTOKINE PRODUCTION AND SECRETION TARGACEPT, INC. (US) 2000-10-26 WO disclosed
EP-1042274-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE R.J. REYNOLDS TOBACCO COMPANY (US) 2000-10-11 EP disclosed
WO-2000023418-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE R.J. REYNOLDS TOBACCO COMPANY (US) 2000-04-27 WO disclosed